NQU-15209-68024 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Dose 1 — Pfizer-BioNTech
2020-12-27
Registered in v-safe
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-29
Survey response — day 7, dose 1
MedDRA: No adverse event — Feeling: Fair · Muscle or body aches, Fatigue or tiredness

Free text: No

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-05
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Chills, Muscle or body aches

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Chills, Headache, Fatigue or tiredness

Adult check-in
2021-01-19
Health check-in — day 7, dose 2
Feeling: Good · Chills

Adult check-in
2021-01-26
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-04
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-16
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-04-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-13
Survey response — 6 months, dose 2
MedDRA: Joint stiffness, Myalgia, Office visit, Polymyalgia rheumatica — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Myalgia joint stiffness - new diagnosis of poly myalgia rheumatatica · Healthcare visit (other): Several visits

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-13
Report sent to call center — 6 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-19
Call 1 — Could Not Reach Participant
2021-07-22
Call successful
Does not wish to fill out VAERS report
2022-01-14
Survey response — 12 months, dose 2
MedDRA: Polymyalgia rheumatica — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Polymyalgia Reumatica

MedDRA releases: 2024-11 · check-in free text available
2022-01-14
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-19
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech

Call center

2 call center cases

1 successful · 1 unsuccessful

See the call center timeline

Free text

Release 1 — day 7, dose 1

2020-12-29

Systemic reaction (other): No

Release 9 — 6 months, dose 2

2021-07-13

Symptoms: Myalgia joint stiffness - new diagnosis of poly myalgia rheumatatica

Healthcare visit (other): Several visits

Release 10 — 12 months, dose 2

2022-01-14

Symptoms: Polymyalgia Reumatica

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	✓	✓	✓
SD	Joint stiffness	✓	✓	✓
SD	Myalgia	✓	✓	✓
SD	Polymyalgia rheumatica	✓	✓	✓
SRO	No adverse event	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release